Patient Perspectives on a Potential New Dermatomyositis Therapy: Insights from Phase 3 VALOR Trial

Join Dr. Prateek Gandiga, a leading expert in dermatomyositis (DM), for a discussion on patient experiences in the VALOR trial, the largest study ever conducted for adults with DM. Explore what patients reported with an investigational once-daily oral medication about their symptoms, daily activities, quality of life, and overall well-being. Understand what these findings may mean for patients with DM and why patient-focused research is so important to advancing care for this condition. Thank you to our sponsor Priovant Therapeutics. Want to learn more about myositis? Be sure to hit like and subscribe to join our growing community. Tap the bell icon 🛎️ so you’ll never miss an update. 🌐https://www.myositis.org/ 📅https://www.myositis.org/calendar/ 💡https://www.myositis.org/about-myositis/ 💻 Originally aired June 17, 2026